HUM vs IMNM · P/E 39, rev $129.66B vs rev $9.0M
Humana Inc (HUM) versus Immunome Inc (IMNM) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Immunome Inc (IMNM) is a biotechnology company listed on US.
Latest reported HUM revenue for 2025-12-31 was $129.66B. Net income was $1.19B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported IMNM revenue for 2024-12-31 was $9.0M. Net income was -$293.0M. Revenue was down 35.5% from 2023-12-31 to 2024-12-31. IMNM currently screens at market cap $2.47B.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. IMNM currently screens at market cap $2.47B.
Not investment advice. Open the HUM and IMNM stock pages for the full models.
Not investment advice.